Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.
Passaro A, Wang J, Wang Y, Lee SH, Melosky B, Shih JY, Wang J, Azuma K, Juan-Vidal O, Cobo M, Felip E, Girard N, Cortot AB, Califano R, Cappuzzo F, Owen S, Popat S, Tan JL, Salinas J, Tomasini P, Gentzler RD, William WN Jr, Reckamp KL, Takahashi T, Ganguly S, Kowalski DM, Bearz A, MacKean M, Barala P, Bourla AB, Girvin A, Greger J, Millington D, Withelder M, Xie J, Sun T, Shah S, Diorio B, Knoblauch RE, Bauml JM, Campelo RG, Cho BC; MARIPOSA-2 Investigators. Passaro A, et al. Among authors: juan vidal o. Ann Oncol. 2024 Jan;35(1):77-90. doi: 10.1016/j.annonc.2023.10.117. Epub 2023 Oct 23. Ann Oncol. 2024. PMID: 37879444 Free article. Clinical Trial.
[Stroke units: more survival. A systematic review].
Ruiz García V, Ramón Bou N, Juan Vidal O, Tembl Ferrairo J. Ruiz García V, et al. Med Clin (Barc). 2005 Jan 15;124(1):22-9. doi: 10.1157/13070436. Med Clin (Barc). 2005. PMID: 15683625 Review. Spanish. No abstract available.
[Thrombopenic purpura caused by tetracyclines?].
Navarro Seisdedos LA, Juan Vidal O, de Paz Arias L, Peláez Hernández A. Navarro Seisdedos LA, et al. Rev Clin Esp. 1998 Aug;198(8):556-7. Rev Clin Esp. 1998. PMID: 9774894 Spanish. No abstract available.
[Chronic diarrhea with uncommon etiology].
Gil Borrás R, Juan Vidal O, Talavera Encinas MI, Bixquert Jiménez M. Gil Borrás R, et al. Gastroenterol Hepatol. 2005 Mar;28(3):110-3. doi: 10.1157/13072009. Gastroenterol Hepatol. 2005. PMID: 15771855 Spanish.
[Detection of dysphagia in the institutionalised elderly].
Ferrero López MI, García Gollarte JF, Botella Trelis JJ, Juan Vidal O. Ferrero López MI, et al. Rev Esp Geriatr Gerontol. 2012 Jul-Aug;47(4):143-7. doi: 10.1016/j.regg.2011.09.004. Epub 2012 Jan 20. Rev Esp Geriatr Gerontol. 2012. PMID: 22264749 Spanish.
Correction to: Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients.
Garde-Noguera J, Martin-Martorell P, De Julián M, Perez-Altozano J, Salvador-Coloma C, García-Sanchez J, Insa-Molla A, Martín M, Mielgo-Rubio X, Marin-Liebana S, Blasco-Cordellat A, Blasco-Molla S, Gironés R, Marquez-Medina D, Aparisi F, Cerda MCB, Macia-Escalante S, Sánchez A, Juan-Vidal O. Garde-Noguera J, et al. Clin Transl Oncol. 2018 Aug;20(8):1096. doi: 10.1007/s12094-018-1916-2. Clin Transl Oncol. 2018. PMID: 29987667
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Garassino MC, Cho BC, Kim JH, Mazières J, Vansteenkiste J, Lena H, Corral Jaime J, Gray JE, Powderly J, Chouaid C, Bidoli P, Wheatley-Price P, Park K, Soo RA, Huang Y, Wadsworth C, Dennis PA, Rizvi NA; ATLANTIC Investigators. Garassino MC, et al. Lancet Oncol. 2018 Apr;19(4):521-536. doi: 10.1016/S1470-2045(18)30144-X. Epub 2018 Mar 12. Lancet Oncol. 2018. PMID: 29545095 Free PMC article. Clinical Trial.
53 results